Adverse Event Duration with Esketamine Versus Quetiapine XR in Adults With Treatment- Resistant Depression: A Subgroup Analysis of ESCAPE-TRD

Authors
Category Primary study
ConferenceNeuroscience Education Institute Congress, NEI 2023
Year 2024
This article has no abstract
Epistemonikos ID: 7e98caaa0399bbb89e403f03e926157bfefadcf6
First added on: Apr 19, 2025